On-Demand Videos

Join Dr. Greco as he discusses the following: • Perspectives on management of metastatic patients with an unclear diagnosis • Approaches to personalized medicine: Is it effective to treat based on molecular alteration alone? • Clinical cases and application of the CancerTYPE ID® Test Speaker: F. Anthony Greco, MD* Tennessee Oncology and OneOncology: Greco-Hainsworth Research Program Sarah Cannon Co-founder of the Research Institute   *Dr F. Anthony Greco, MD is a medical consultant for Biotheranostics, Inc., A Hologic Company. Statements reflect the speakers' own personal views and interpretations, and not necessarily those of Hologic.